14th Biennial Congress of the European Association of Oral Medicine in conjunction with the World Workshop

on Oral Medicine VII

PROGRAMME 27th–29th September 2018

w w w . e a o m 2 0 1 8 . s e

EAOM 2018・GOTHENBURG

32

Sponsors

Exhibitors

EAOM 2018・GOTHENBURG

14TH BIENNIAL CONGRESS OF THE EUROPEANASSOCIATION OF ORAL MEDICINE IN CONJUNCTIONWITH THE WORLD WORKSHOP ON ORAL MEDICINE VII

Under the auspices of the European Association of Oral Medicine, University of Gothenburg

and the Public Dental Service, Region Västra Götaland, Sweden

MHCF

WELCOME MESSAGE

FROM THE PRESIDENT

My dear Colleagues and Friends,

The European Association of Oral Medicine (EAOM) will hold its 14th biennial meeting in Gothenburg, alongside the World Workshop in Oral Medicine (WWOM) VII. We are honoured and delighted to host the WWOM VII, and look forward to listening to the findings of the various groups. It is a significant time for both organi-zations: WWOM is marking its 30th year since its establishment, and EAOM is celebrating its 20th anniversary.

The EAOM Board and the Local Organizing Committee have been working tirelessly to prepare an exciting programme that brings together many highly renowned and talented speakers from a range of backgrounds. The scientific component of the meeting will include lectures, slide seminars, case and scientific presentations and interactive sessions to match the highest expectations of research and scholarship.

As a part of the satellite activities, we will proudly continue to offer interested den-tists and physicians the possibility to sit an examination for the EAOM Diploma.

Since its foundation, EAOM has grown and expanded steadily reflecting the incre-asing worldwide importance of Oral Medicine as a dental specialty. Amongst other reasons, this has convinced the EAOM Board to officially outline and present our viewpoint on the diagnosis and management of four of the most common oral dise-ases seen by specialists in Oral Medicine, in the form of position papers.

We can anticipate that in September in Gothenburg you will have the unique chance to meet up and network with many key international colleagues from across the world. Sadly, one of the founding fathers of EAOM, Professor Crispian Scully, passed away last year, and EAOM has chosen to honour his memory by naming the first key talk of the meeting after him.

I look forward to welcoming you to Gothenburg.

My very best wishes to you all, Professor Marco Carrozzo EAOM President

Gold Sponsor Bronze SponsorSilver Sponsor

54

The Local Organizing Committee (LOC) for the 14th Biennial Congress of the European Association of Oral Medicine (EAOM) is honoured to welcome you all to Gothenburg. This is the second time Gothenburg hosts an EAOM congress. The first time, in 2000, almost 200 dele-gates attended the meeting. During the last 18 years the field of oral medicine has developed both regarding clinical care and research. This year, we wel-come more than 500 delegates from all over the world to the west coast of Sweden.

The scientific programme has the theme “Current challenges become future developments in oral medicine”. The delegates consist of prominent rese-archers in the field of oral medicine as well as renowned researchers in other fields of life sciences. The latest scientific results will be shared through both oral scientific presentations and a poster exhibition. Almost 200 posters will be at hand during Friday and Saturday. Clinical cases will also be presented.

An important part of an EAOM meeting is the clinico-pathological conference (CPC). In this session, a challenging clinical case is presented by a discussant that is unaware of the correct diagnosis. Together with the colleague that has submitted the case, a discussion follows that eventually will lead to a correct diagnosis. This session enables both cli-nicians and scientists to gain knowledge about rare cases and diagnostic pitfalls.

The EAOM congress is preceded by the World Workshop on Oral Medicine (WWOM) VII during the first days of the

week. WWOM members have pursued the challenging task to retrieve and com-pile state of the art on a number of sub-jects within the scope of oral medicine. The results from the workshop will be presented to the delegates attending the EAOM meeting. This will further increase the scientific level of the meeting. The LOC joins in the President´s statement that we are honoured to welcome the faculty from the WWOM VII to the 14th Biennial Congress of the EAOM. We in the LOC also extend a special thanks to the WWOM organizing committee for an excellent and enjoyable collaboration in the preparation for the two meetings.

EAOM and the LOC also sincerely welcome our sponsors and exhibitors. The companies and organizations that participate in EAOM 2018 are an impor-tant part of the meeting and makes the essential interaction between science, clinics and industry possible. We urge all delegates to visit the exhibition and dis-cuss with our sponsors and exhibitors.

The city of Gothenburg in the autumn can offer sunshine, but also wind and rain. The city is easy to get around in. In the city center you will find shopping, be-autiful parks and excellent restaurants.

The members of the Local Organizing Committee hope you will enjoy the congress and wish you a heartily welcome to Gothenburg and the west coast of Sweden.

Bengt Hasséus (Chair), Inger von Bültzingslöwen, Agne Nihlson Jairo Robledo-Sierra, Maria Bankvall Per-Olof Rödström, Mats Jontell (Senior Advisor), Jonas Sundberg, Lena Lindahl

Welcome to Gothenburg

76

FacultyAlajbeg Ivan (Croatia) Ariyawardana Anura (Australia)Beier-Jensen Siri (Denmark)Bez Cristina (Italy)Bratel John (Sweden)Brennan Michael T (USA)Carrozzo Marco (Italy)Cirillo Nicola (Australia)Delli Konstantia (Netherlands)De Rossi Scott (USA)Drangsholt Mark (USA)Ekenstråle Emma (Sweden)Escudier Michael (UK)Farah Camile (Australia)Farag, Arwa (Saudi Arabia)Fedele Stefano (UK)Frandsen Lau Ellen (Denmark)Garming-Legert Karin (Sweden)Glurich Ingrid (USA)Greiner Thomas (Sweden)Gueiros Luiz (Brazil)Hansson Gunnar C (Sweden)Hasséus Bengt (Sweden)Hong Catherine (Singapore)Jontell Mats (Sweden)Kerr Ross (USA)Kjeller Göran (Sweden)Lodi Giovanni (Italy) Lockhart Peter (USA)Löfhede Helena (Sweden)Mays Jacqueline (USA)Mignogna Michele D (Italy) Moutsopoulos Haralambos M (Greece) Nikitakis Nikolaos G (Greece) Patton Lauren (USA)Pentenero Monica (taly)Porter Stephen (UK)Ragnarsson Oskar (Sweden)

Rasmusson Lars (Sweden)Robledo-Sierra Jairo (Colombia)Rosin Miriam (Canada)Rozema Fred (Netherlands) Sardella Andrea (Italy)Selga Guntars (Latvia)Setterfield Jane (UK)Shepherd Martina (UK)Siponen Maria (Finland)Sjöberg Wivi-Anne (Sweden)Sklavounou Alexandra (Greece)Stenman Göran (Sweden)Svensäter Gunnel (Sweden)Taylor Jennifer (UK)Tovaru Serban (Romania)Varoni Elena (Italy)Villa Alessandro (USA)Vissink Arjan (Netherlands) von Bültzingslöwen Inger (Sweden) Warfvinge Gunnar (Sweden)Wertsén Madeleine (Sweden)Westin Maria (Sweden)Wolff Andy (Israel) Yarom Noam (Israel)Zambruno Giovanna (Italy)Öhman Jenny (Sweden)

International Scientific Committee

ChairMarco Carrozzo, UK

Co-ChairsMichael Escudier, UKNikolaos Nikitakis, Greece

MembersBlomgren Johan, SwedenByun Jin-Seok, KoreaCarneiro Leão Jair, Brazil Çevik-Aras Hülya, SwedenDelli Konstantina, Netherlands di Fede Olga, ItalyFarah Camile S, AustraliaFedele Stefano, UKFortuna Giulio, ItalyHasséus Bengt, SwedenJontell Mats, SwedenKoray Meltem, TurkeyLo Muzio Lorenzo, ItalyLockhart Peter, USAMignogna Michele D, ItalyPeterson Douglas, USAPorter Stephen, UKPoulopoulos Athanasios, Greece Robledo-Sierra Jairo, Colombia Rozema Fred, Netherlands Siponen Maria, FinlandSpijkervet Fred, Netherlands Vissink Arjan, Netherlands von Bültzingslöwen Inger, Sweden Willis Amanda, UKYarom Naom, IsraelÖhman Jenny, Sweden

CommitteesLocal Scientific Committeevon Bültzingslöwen Inger (Chair)Hasséus BengtBratel JohnÇevik-Aras HülyaGarming-Legert KarinMattsson UlfRobledo-Sierra JairoRödström Per-OlofWarfvinge GunnarÖhman Jenny

World Workshop On Oral Medicine VII Organizing CommitteeBeier Jensen Siri, DenmarkGreenberg Martin, USAHodgson Tim, UKKerr Ross, USA Lockhart Peter, USALodi Giovanni, ItalyPeterson Douglas, USA

Professional Congress Organizer

Sweden MEETX ABE-mail: eaom2018@meetx.sePhone: +46 31 708 86 90Postal address:Sweden MEETX ABRef. EAOM2018412 94 GothenburgSweden

98

Programme overviewSeptember 27 September 28 September 29

Thursday Friday Saturday10:00

Examination for the diploma in Oral medicine07:00-17:30

Registration open07:30-18:00

Registration open

14:00EAOM Board meeting

08:00-10:00Scientific programme

07:45-09:30Scientific programme

14:00-20:30Registration open

10:00-10:30Coffee break, exhibition and poster viewing

09:30-10:15Coffee break, exhibition and poster viewing

18:00Congress opening

10:30-12:30Scientific programme – Parallel sessions

10:15-12:15Scientific programme

Opening ceremony 12:30-13:30Lunch break, exhibition and poster viewing

12:15-13:45Lunch break, exhibition and poster viewingPre-Symposium

Crispian Scully Lecture13:30-15:30

Scientific programme – Parallel sessions12:15-13:45

Lunch and learningSJÖGREN´S SYNDROME: FROM BENIGN TO MA-LIGNANT LYMPHOPROLIFERATION

Haralambos M. Moutsopoulos Professor University of Athens, Greece 15:30-16:00

Coffee break, exhibition and poster viewing13:45-16:45

Scientific programme – Parallel sessions19:30-21:30

Welcome Reception hosted by the City of Gothenburg and Region Västra GötalandVenue: Lindholmen Conference Center

16:00-17:15Scientific programme

14:45-15:45Coffee is served

17:30-18:30General assembly

17:00-17:15Presentation of next EAOM-meeting

17:15-17:30Closing remarks

19:30-00:30Congress Dinner

Venue: Restaurant Kajskjul 8

1110

Detailed programme“Current challenges become future developments in oral medicine”

THURSDAY 18.00-19.30

18.00-19.30 Congress Opening and Pre-SymposiumSession Room: Conference Hall

Opening Ceremony

Pre-Symposium Crispian Scully LectureSjögren´s syndrome: a disorder expan-ding from benign to malignant lymp-hoproliferationHaralambos M. Moutsopoulos, Greece

19:30-21:30 Welcome ReceptionHosted by the City of Gothenburg and Region Västra GötalandVenue: Lindholmen Conference Center

FRIDAY 08.00-17.15

08.00-8.10 Welcome and practical informationSession room: Conference HallPresident Local Organising Committee Bengt Hasséus, Sweden

08.10-10.00 EAOM position papersSession room: Conference Hall Session chairs: Marco Carrozzo, UK and Alexandra Sklavounou, Greece

ORAL LICHEN PLANUSStefano Fedele, UK

LEUKOPLAKIACamile Farah, Australia

RECURRENT APHTHOUS STOMATITISJennifer Taylor, UK

BURNING MOUTH SYNDROMEAndrea Sardella, Italy

10.00-10.30 COFFEE BREAK EXHIBITION & POSTER VIEWING

10.30-12.30 PARALLEL SESSIONS

PARALLEL SESSION 1: Prediction of cancer development and prognostic evaluation. New trends in diagnosticsSession room: Conference Hall Session chairs: Fred Rozema, Netherlands and Guntars Selga, Latvia

MOLECULAR BIOLOGY, MICRO-RNA, EPIGENETICS, PREDICTIVE MARKERS AND DIAGNOSTICSMonica Pentenero, Italy

MEDICAL IMAGING COMPARED TO CONVENTIONAL TECHNIQUES, ADVANCES IN DIAGNOSTIC OPTICAL IMAGINGCamile Farah, Australia

BIOLOGICAL MARKERS FOR RISK PREDICTION OF EARLY PREMALIG-NANT LESIONSMiriam Rosin, Canada

CHROMOSOME TRANSLOCATIONS AND FUSION ONCOGENES IN THE GE-NESIS OF SALIVARY GLAND TUMORSGöran Stenman, Sweden

PARALLEL SESSION 2: Case presenta-tionsSession room: Pascal Session chairs: Maria Westin, Sweden and Michael T. Brennan, USA

Management of facial deformity (orofacial granulomatosis) and parental concerns of bullying – a report of two casesMelanie Simms, UK

Jacob’s syndrome. Presentation of three clinical casesMaria Magaix-Muñoz, Spain

Same PTEN gene mutation found in two relatives with Cowden SyndromeMartin Giorgio Campolongo, Italy

Localized juvenile spongiotic gingival hyperplasia: report of two casesVasileios-Ionas Theofilou, Greece

Oral lichen planus and thymoma. Report of two casesIoanina Mihaela Parlatescu, Romania

Oral aphthous-like ulcers associated with a selective PI3K inhibitorSavvas Titsinides, Greece

Oral ulceration with bone sequestration: report of eight casesEleni-Marina Kalogirou, Athens, Greece

mTOR inhibitor-associated stomatitis breakthrough in a kidney recipient patientFabiana Martins, Brazil

Orofacial granulomatosis post haema-topoietic stem cell transplantationCraig Whitelaw, UK

Epithelial haemangioma of the buccal mucosa: a case reportCraig Hogg, UK

Swelling in the zygomatic region as a first sign of non-small cell lung cancer: presentation of two casesElisabeth Brouns, Netherlands

Oral amelanotic melanoma: a silent killerDimitrios Maloutas, Greece

12.30-13.30 LUNCH BREAK EXHIBITION AND POSTER VIEWING

13.30-15.30 The barrier functions of the mucosaSession room: Conference Hall Session chairs: Inger von Bültzingslöwen and John Bratel, Sweden

MOUTH, LUNG AND GASTROINTESTINAL TRACT; MUCUS AND MUCINSGunnar C Hansson, Sweden

GASTROINTESTINAL TRACT; MUCOSAL MICROBIOME IN HEALTH AND DISEASEThomas Greiner, Sweden

ORAL BIOFILM – FRIEND OR FOEGunnel Svensäter, Sweden

13.30-15.30 Parallel Session: Slemhinneförändringar som du ser i din kliniska vardag (Session in Swedish about oral mucosal diseases you may encounter in everyday clinical practice)Session room: PascalWivi-Anne Sjöberg, Emma Ekenstråle, Sweden

15.30-16.00 COFFEE BREAK EXHIBITION AND POSTER VIEWING

1312

16.00-17.15 Immunomodulating treatments of oral conditions (effects, risks, side effects)Session room: Conference Hall Session chairs: Jane Setterfield, UK and Cristina Bez, Italy

IMMUNOMODULATING TREATMENTS OF ORAL MUCOSAL DISEASESStephen Porter, UK

SYSTEMIC EFFECTS OF LOCAL GLUCO-CORTICOID TREATMENT FOR ORAL CONDITIONSOskar Ragnarsson, Sweden

17.30-18.30 General assemblySession room: Conference Hall

SATURDAY 07.45-17.15

07.45-9.30 World Workshop on Oral Medicine (WWOM) VIISession room: Conference Hall Session chairs: Peter Lockhart, USA and Siri Beier Jensen, Denmark

Group 1 – Oral Microbiome Ellen Frandsen Lau, Denmark; Elena Varoni, Italy; Jairo Robledo- Sierra, Colombia

Group 2 – Precision Medicine Ingrid Glurich, USA; Konstantina Delli, Netherlands; Alessandro Villa, USA

Group 3 – Molecular Biology Monica Pentenero, Italy

Group 4 – Use of Biologics in Oral MedicineScott De Rossi, USA; Jacqueline Mays, USA; Luiz Gueiros, Brazil

Group 5 – Consensus on Outcome Measures for Burning Mouth

Arwa Farag, Saudi Arabia and Anura Ariyawardana, Australia

9.30-10.15 COFFEE BREAK, EXHIBITION AND POSTER VIEWING

10.15-11.15 WWOM VII continuedSession room: Conference Hall Session chairs: Ross Kerr, USA and Giovanni Lodi, Italy

Group 6 – Future of Oral Medicine Mark Drangsholt, USA

Group 7 – Medically Necessary Dental CareLauren Patton, USA

Group 8 – Pediatric Oral Medicine Catherine Hong, Singapore

11.15-12.15 From lab to patientSession room: Conference Hall Session chairs: Michael Escudier and Martina Shepherd, UK

TISSUE REGENERATION AND 3D-PRINTINGLars Rasmusson, Sweden

FROM GENE DISORDERS TO BEDSIDE THERAPY: THE JOURNEY OF RESEARCH IN BLISTERING DISEASESGiovanna Zambruno, Italy

12.15-13.45 LUNCH BREAK, EXHIBITION AND POSTER VIEWING

12.15-13.45 LUNCH AND LEARNING2×8 tables, 11 participants/table.

To what extent can the clinician trust the pathologist and vice versa? What can go wrong from biopsy to diagnosis – some challenging cases.Gunnar Warfvinge and Jenny Öhman, Sweden

Sjögren’s syndrome: where are we today?Arjan Vissink, Netherlands and Haralambos M. Moutsopoulos, Greece

H&N Cancer: short and long-term monitoring and management of oral sequelae after treatment.Göran Kjeller and Maria Westin, Sweden

Management of oral GVHD. Criteria for monitoring. Cancer development?Noam Yarom, Israel and Karin Garming-Legert, Sweden

Stimulating orofacial motor function in patients with orofacial disabilities.Madeleine Wertsén and Helena Löfhede, Sweden

Clinical and lab-based research: how to design, perform and publish a good study.Giovanni Lodi, Italy and Nicola Cirillo, Australia

How to plan a strategy of fund raising for R&D projects.Andy Wolff, Israel and Mats Jontell, Sweden

Clinical leadership – why it is important.Michael Escudier, UK

13.45-16.45 PARALLEL SESSIONS

PARALLEL SESSION 1: Clinicopathological case conferenceSession room: Conference Hall Session chairs: Nikolaos G. Nikitakis, Greece and Jairo Robledo-Sierra, Colombia

Case 1. Dr Konstantina Delli, Netherlands – contributor and Dr Cornelia Wilkert, Netherlands – discussantCase 2. Dr Alexandra Sklavounou, Greece – contributor and Dr Amal Dafar, Saudi Arabia – discussant

Case 3. Dr Martyn Ormond, UK – contri-butor and Dr Gita Gale, Sweden – discus-santCase 4. Dr Per-Olof Rödström, Sweden – contributor and Dr Barbara Carey, UK – discussantCase 5. Dr Marco Meleti, Italy – contri-butor and Dr Jose Manuel Aguirre Urizar, Spain – discussantCase 6. Dr Ludmila Lukach, Israel – contri-butor and Dr Ivana Skrinjar, Croatia – discussantCase 7. Dr Arwa M. Farag, USA – contri-butor and Dr Alessandro Villa, USA – dis-cussant

PARALLEL SESSION 2: Oral scientific presentations

Oral scientific presentations ISession room: Pascal Session chairs: Ivan Alajbeg, Croatia and Maria Siponen, Finland

Investigating the genetic architecture of orofacial granulomatosisYasmin Omar, UK

Non-invasive screening for molecular dysplasia in oral potentially malig-nant disordersTami Yap, Australia

Quantification of green tea’s effect on oral cancer cells, is this caused by EGFR inhibition?Simone Belobrov, Australia

Sialendoscopy increases salivary secretion and reduces xerostomia in patients with Sjögren’s syndrome: a 60 weeks randomized, controlled, single blind studyHakki Karagozoglu, Netherlands

Novel fibroblast-derived 3D constructs to examine the role of the extracellular matrix in oral cancer progressionHelen Colley, UK

1514

Interleukin 17-producing cells and Tc1 effectors drive pathogenesis of chronic graft-versus-host disease in the oral cavityJacqueline Mays, USA

Oral scientific presentations IISession room: Pascal Session chairs: Michele D. Mignogna, Italy and Serban Tovaru, Romania

Associations of oral infections with six-month survival after hematopoie-tic stem cell transplantationMatti Mauramoi, Finland

A translational journey on the effica-cy of hyaluronic acid in the preven-tion of oral mucositis: results of a phase 2 trial.Nicola Cirillo, Australia

Clinical outcome of dental extractions in renal transplant recipients — preli-minary resultsRubens Caliento, Brazil

Correlation between overexpression of p16 and the presence of human pa-pilloma virus in oral leukoplakia and oral squamous cell carcinomaJonas Sundberg, Sweden

XEROMeds consortium: the impact of medications on stimulated and unsti-mulated salivary flow rate in patients with non-Sjögren’s related siccaMichael T. Brennan, USA

Pilocarpine spray for the treatment of xerostomia in patients with Sjögren’s syndrome: a randomized, double-blind, placebo-controlled trialAna Carolina Motta, Brazil

17.00 – 17.15 Presentation of next EAOM meetingSession room: Conference Hall

17.15-17.30 Closing remarksSession room: Conference Hall

19:30-00:30 Congress DinnerVenue: Restaurant Kajskjul 8

Posters Friday

Fri-01

Measurement properties of self-ad-ministered health-related quality of life instruments used in recurrent aphthous stomatitisWiriyakijja P, Assas M, Fedele S, Porter S, Ni Riordain R

Fri-02

Bacterial aggregation in the saliva of patients with recurrent aphthous stomatitisRahimi A, Jontell M, Bankvall M, Cevik Aras H

Fri-03

Vitamin D deficiency among patients with recurrent aphthous stomatitis: a preliminary study from the UAEAl-Amad S, Hasan H, Awad M

Fri-04

Dietary habits among patients with recurrent aphthous stomatitisCzerninski R, Zini A, Levin O, Almoznino G

Fri-05

Efficacy study on Bexident AFTAS gel, spray and oral rinse used in aphthous stomatitis treatmentPedersoli L, Dalessandri D, Laffranchi L, Bindi M, Bonetti S, Visconti L

Fri-06

Recurrent aphthous stomatitis: a retrospective study in a group of Thai dental patientsPanpradit N, Maipanich S

Fri-07

Clinical estimation of dental anxietyHöglund M, Bågesund M, Shahnavaz S, Wårdh I

Fri-08

Characteristics of the patients who perceived dental treatment as a cau-se of oral mucosal lesionsJu H, Ok S, Jeon H, Kim K, Jeong S

Fri-09

Awareness of oral cancer among adults in Jakarta, IndonesiaWimardhani Y, Warnakulasuriya S, Subita G, Soegyanto A, Pradono S, Patoni N

Fri-10

Differences in collagen XVII expres-sion between skin and oral mucosa affect the pathogenicity of pemphi-goid IgGKamaguchi M, Iwata H, Ujiie H, Natsuga K, Nishie W, Asaka T, Shimizu H, Kitagawa Y

Fri-11

Chronic oral graft-versus-host dis-ease: salivary cytokines as markers of diseaseHull K, Kerridge I, Avery S, Ritchie D, Szer J, Mccullough M

Fri-12

The role of immune reactions in the pathogenesis of pemphigus vulgaris of the oral mucosaRabinovich O, Rabinovich I, Abramova E

1716

Fri-13

A retrospective study of immune dys-regulated dermatological disorders and their oral manifestations in the Omani populationSaraf S, Nalwade T

Fri-14

Oral health related quality of life is associated with both disease severity and activity in patients with autoim-mune bullous diseaseBilgic-Temel A, AydıN F, Sumer P, Keskiner I, Koc S, Bozkurt S, Mumcu G, Alpsoy E, Uzun S, Akman-Karakas A

Fri-15

Mucous membrane autoimmune bul-lous diseases: a 20-years retrospective study at a tertiary oral medicine unitCalabria E, Fortuna G, Leuci S, Lamanna A, Coppola N, Mignogna M

Fri-16

Paraneoplastic pemphigus associated with tymomaMinicucci E, Ferreira E, Bastos L, Schmitt J, Marques M

Fri-17

Is a “punch on the gum” the way you need to diagnose oral blistering disease?Gilvetti C, Barret B, Collyer J

Fri-18

Psoriatic arthritis with tongue mani-festations. Report of an unusual caseAndreadis D, Zisis V, Theodoridou A, Anag-nostou E, Poulopoulos A

Fri-19

The optimal oral biopsy site: punch biopsy of uninvolved buccal mucosa is equally sensitive to perilesional tissue for diagnosis of oral pemphigus and pemphigoidCarey B, Joshi S, Adbelghani A, Andiappan M, Setterfield J

Fri-20

Liver enzyme levels, lipid profiles and cardiovascular risk in patients with oral lichen planusCigic L, Radic T, Glavina A, Biocina-Lukenda D

Fri-21

Oral lichen planus and malignacyTovaru S, Parlatescu I, Nicolae C, Tovaru M

Fri-22

Assessment of the psychometric properties of the hospital anxiety and depression scale in patients with chronic ulcerating oral mucosal diseaseAlamoudi W, Al-Jalili R, Tariq N, Ni Riordain R, Porter S

Fri-23

Chronic mucocutaneous ulcerative disorder with SES-ANA: a case report and detailed review of CUSAzzi L, Croveri F, Tagliabue A, Tettamanti L

Fri-24

Oral lichen planus of the gingiva and its management in a group of Portu-guese patientsHenriques I, Pinto A, Cardoso I, Monte-negro R, Rebelo H, Trancoso P, Mano Azul A

Fri-25

Pemphigus vulgaris: a 25 years ret-rospective study in a Brazilian oral medicine serviceNavarro C, Grifoni L, Lamonato T, Onofre M, Bufalino A

Fri-26

Undifferentiated connective tissue disease arising in an ectodermal dys-plasia patient: a case reportOkuma N, Okuma N, Panpradit N, Maipa-nich S

Fri-27

Review of the current international consensus on burning mouth syn-drome: treatment optionsSato J, Kitagawa Y, Asaka T, Ohga N, Tsuchiya E, Yamashita E, Satoh C

Fri-28

The efficacy of fluoxetine in primary BMSZoric B, Jankovic L, Kuzmanovic Pficer J, Zidverc-Trajkovic J, Mijajlovic M, Hadzi Mihailovic M, Stanimirovic D

Fri-29

Treatment outcome of venlafaxine and duloxetine in refractory BMS patientsKim M, Kho H

Fri-30

Usefulness of a cannabis-based medi-cation in patients with burning mouth syndrome: preliminary results of a prospective pilot studyGambino A, Panagiotakos E, Cabras M, Cafaro A, Broccoletti R, Arduino P

Fri-31

Influences of systemic oxidative stress levels on therapeutic efficiency of tocopherol in treatment of burning mouth syndrome: preliminary studyKang J

Fri-32

Vortioxetine in the treatment of mood disorders associated with burn-ing mouth syndrome: results of an open label, flexible-dose pilot studyAdamo D, Pecoraro G, Fortuna G, Ruoppo E, Carbone R, Mignogna M

Fri-33

Evaluation of the efficacy of low level laser therapy in the burning mouth syndromeDe Pedro M, López-Pintor R, Casañas E, Ramírez L, Hernández G

Fri-34

Thyroid disorders and the burning mouth syndrome etiopathogenesisCoculescu E, PăRlăTescu I, Nicolae C, ȚOvaru &, Coculescu B

Fri-35

Saliva and associated factors in pa-tients with burning mouth syndrome (BMS)Acharya S, Hägglin C, Jontell M, Wenneberg B, Ekström J, Sandell M, Carlén A

Fri-36

EGFR blockade inhibits uptake of tumor cell-derived exosomes through macropinocytosis in oral squamous cell carcinomaSasabe E, Liu H, Tomomura A, Tomita R, Sento S, Yamamoto T

1918

Fri-37

Prevention and prognosis of DRONJ : a retrospective study of 37 patientsBroly E, Barthélémy P, Severac F, Gros C, Feki A, Kurtz J, Bornert F

Fri-38

Evaluation of the inhibitory effects of caffeine on human carcinoma cells: a primary studyTonkaboni A, Lotfi Bakhshaiesh N, Danesh P, Tajerian R, Kargozar S

Fri-39

Ubiquitin specific peptidase 13 pro-motes cell invasion in head and neck squamous cell carcinoma by interact-ing with and stabilizing BMI-1He M, Chen Q, Wan Y

Fri-40

Oral mucositis and microbial colonisa-tion in oral cancer patients undergo-ing radiotherapy and chemotherapy - a prospective analysis in a tertiary care dental hospitalSubramaniam N, Subramaniam N, Muthukrishnan A

Fri-41

Oral cavity condition in patients with acute myeloid leukaemia after allogeneic peripheral blood stem cell transplantationWysocka-SłOwik A, Gil L, Slebioda Z, Bart-kowiak A, Dorocka-Bobkowska B

Fri-42

Oral cancer - knowledge and risk per-ception in the screening populationBrailo V, Andabak Rogulj A, Brzak LončAr B, Vidović Juras D, Škrinjar I, VučIćEvić Boras V, Alajbeg I

Fri-43

Oral shedding of human herpesvirus and the association with xerostomia in patients undergoing radio/chemo-therapy treatment for squamous cell carcinoma in head and neck regionPalmieri M, Pereira Ornaghi M, Brandão T, Correa L, Massami Sumita L, Tozetto-Men-doza T, Braz-Silva P

Fri-44

Oral cancer and potentially malignant lesions: knowledge, attitudes and practices of Portuguese dentistsPinto A, Henriques I, Cardoso I, Louraço A, Freitas F, Trancoso P, Azul A

Fri-45

Prognosis of oral squamous cell carci-noma in association with oral lichen planusPimolbutr K, Porter S, Fedele S

Fri-46

Environmental and behavioral head and neck cancer risk factorsVucicevic Boras V, Fucic A, Blivajs I, Bisof V, Ceppi M, Bruzzone M, Baranovic S

Fri-47

Polyomavirus JC detected in adenoid cystic carcinoma of trachea, parana-sal sinuses and oral cavityHämetoja H, Jaana H, Caj H, Leif B, Antti M, Stina S

Fri-48

The induction of epithelial-mesenchy-mal transition in oral epithelial cells by fusobacterium nucleatum - prelim-inary resultsAlnafea S, Nair S, Fedele S

Fri-49

Targeting MMP2 with monoclonal antibodies in oral squamous cell carci-nomaCelentano A, Cirillo N, Mccullough M

Fri-50

Differential expression of CYP1A1, CYP1B1, CYP2A6 and CYP2E1 in oral squamous cell carcinoma from smok-ers and non-smokersÁvila Almeida A, Muller Bandeira C, Oliveira Alves M, Nogueira Paschoal M, De Salles Chagas J, Pimentel De Barros P, Daumas Nunes F, Faig Lima Carta C, Dias Almeida J

Fri-51

Brush biopsy for HR-HPV detection with FTA card and ai for cytology anal-ysis - a viable non-invasive alternativeRunow Stark C, Gustavsson I, Gyllensten U, Darai Ramqvist E, Lindblad J, Wahlby C, Bengtsson E, Hirsch J

Fri-52

Podoplanin as a potential predictive biomarker of malignant transforma-tion in oral leukoplakiasMonteiro L, Delgado L, Amaral B, Salazar F, Pacheco J, Warnakulasuriya S

Fri-53

Loss of occludin is indicative of poor survival in oral squamous cell carci-nomasDelgado L, Monteiro L, Amaral B, Salazar F, Pacheco J, Warnakulasuryia S

Fri-54

Metastatic tumors to the jawbones - report of 10 casesAndabak Rogulj A, Tomasovic Loncaric C, Mueller D, Blivajs I, Andabak M, Vucicevic Boras V

Fri-55

Interventions for preventing and/or managing radiation-induced-fibrosis to the head and neckValeria M, Alsoghier A, Porter S, Fedele S

Fri-56

Analysis of salivary cytokines and chemokines in early and late stages of oral squamous cell carcinoma (OSCC)Dikova V, Principe S, Bagan J, Jantus - Lewintre E, Camps C

Fri-57

Acute oral complications in patients undergoing radio/chemotherapy treatment for squamous cell carcino-ma in the head and neck regionMichelle P, Victor Adriano D, Bruna B, Thais Bianca B, Ana Carolina Prado R, Luciana C, Braz-Silva P

Fri-58

Human papillomavirus infection and sexual habits in a population of young Italian adultsVaroni E, Franchini R, Noviello V, Moneghini L, Lodi G

Fri-59

Nutritional status assessment of head and neck cancer patients: a cross-sec-tional studyVaroni E, Sardella A, Pischetola S, Spallino G, Iriti M

Fri-60

FASN and GLUT-1 expression in the malignant transformation of the pleo-morphic adenomaFernandes L, Carvalho L, Scarini J, Egal E, Tincani Á, Del Negro A, Bastos D, Kowalski L, Altemani A, Mariano F

2120

Fri-61

HMGA2 expression in pleomorphic adenoma, recurrent pleomorphic ade-noma and carcinoma ex-pleomorphic adenomaCarvalho L, Fernandes L, Scarini J, Egal E, Martins A, Casarim A, Bastos D, Kowalski L, Altemani A, Mariano F

Fri-62

Measurement properties of pa-tient-reported outcome measures in radiotherapy-induced trismusAssas M, Wiriyakijja P, Mercadante V, Ni Ríordáin R, Fedele S, Porter S

Fri-63

Retrospective study of oral dysplasia and squamous cell carcinoma devel-oped in patients with graft versus host diseaseFricain J, Fricain J, Morel F, Catros S, Fenelon M

Fri-64

Salivary cytokines and chemokines in patients affected by oral squamous cell carcinoma. A case-crossover studyVal M, Manini L, Marino R, Pentenero M

Fri-65

Melanoma of the oral mucosa. Clinical casePoveda-Roda R, Margaix-Muñoz M, Bagán-Debón L, Bagán J

Fri-66

Diffuse large B-cell lymphoma of the oral cavityJimenez Y, Gavalda C, Sanchis J, Rubert A, Bagán J

Fri-67

Colon adenocarcinoma metastasis to the mandible: a case reportGavaldá C, Rubert A, Sarrión M, Bagán J

Fri-68

Clinical case: multiple myeloma with initial manifestations in the oral cavityJose Vicente B, Rafael P, Manuel L, Jose Maria S

Fri-69

Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: a systemat-ic reviewSaka C, Jané-Salas E, Estrugo Devesa A, Rodriguez de Rivera E, López-López J

Fri-70

Current approaches to early diagnosis of oral squamous cell carcinoma: case seriesAk G, Hacioglu E, Acikgoz M, Yurtseven A

Fri-71

The role of computer guided implan-tology during complex dental treat-ment under general aesthesiaMichaeli E, Pettesh J

Fri-72

Importance of eliminating potential dental focal infection before hema-topoietic stem cell transplantation: a retrospective cohort study in JapanShimada Y, Kawasaki Y, Hagiwara S, Na-kamura F, Maruoka Y

Fri-73

Should we assess TAVI patients the same as valve surgery patientsPorat Ben Amy D, Sholy H, Shmuel C, And-ria N, Diab G, Sudarsky D, Amir O, Carasso S, Kusniec F, Abu El-Naaj I

Fri-74

Impact of oral health on outcomes of renal transplantationGallottini M, Sarmento D, Caliento R, Sa-intclaire R, Braz-Silva P, Lockhart P

Fri-75

Cross-cultural adaptation and psy-chometric properties analysis of the European medical risk-related history (EMRRH) questionnaire for use in the Indonesian-speaking populationBaringbing A, Subita G, Wimardhani Y

Fri-76

The antifungal susceptibility to octenidol and chlorhexidine of can-dida spp. Oral isolates from patients with denture stomatitisDziedzic A, Wiench R, Wojtyczka R, Tana-siewicz M, Lodi G, Varoni E, Iriti M

Fri-77

Sino-palatal-vestibular mucormycosis and aspergillosis in a patient with acute b lymphoblastic leukaemiaVidovic Juras D, Jurlina M, Brailo V, Gabric D, Duric Vukovic K, Roncevic P, Jandrlic M, Vucicevic Boras V

Fri-78

Close relationship between the palmoplantar pustulosis and dental treatmentAsaka T, Morimoto M, Sato J, Ohga N, Kitagawa Y

Fri-79

Self-reported oral and dental experi-ence of patients with sclerodermaAbdouh I, Ni Riordain R, Fedele S, Porter S

Fri-80

Oral and dental findings in Hamamy syndromeHassona Y, Al Banna S

Fri-81

Current oral surgical approaches to hemophiliac patients: case seriesAk G, Acıkgoz M, Yurtseven A, Hacioglu E

Fri-82

Impacted canine surgery in a patient with homocystinuria: a case reportAk G, Yurtseven Gunay A, Acikgoz M, Akbıyık Az Z

Fri-83

Salivary cardiac troponin I as a po-tential marker for detection of acute myocardial infarctionKhanna V, Mishra V

Fri-84

Salivary Extracellular Vesicles microR-NAs as a fitting non-invasive source for biomarkers in oral oncology: A prospective study.Arduino P, Gai C, Gambino A, Cabras M, Camussi F, Broccoletti R, Camussi G

Fri-85

The expression of insulin-like growth factor 2 (IGF2) in patients with oral lichen planus and diabetes mellitusLoncar Brzak B, Sabol I, Veliki-Dalic I, Krušlin B, Mravak-Stipetic M

2322

Fri-86

Chronic graft-versus-host disease oral mucosal histopathological grading moduleTollemar V, Garming-Legert K, Nikolce T, Heymann R, Sugars R, Warfvinge G

Fri-87

Interim performance of an oral rinse point-of-care assay to aid in the diag-nosis of oral squamous cell carcinoma (OSCC) in a German oral-maxillofacial surgery university clinicDonovan M, Forster A, Precht C, Franz-mann E, Ginn G, Hanken H, Smeets R

Fri-88

Salivary metabolomics in the early diagnosis of head and neck squamous cell carcinomaFerrazzo K, Willrich de Melo L, Hennemann B, Ferrazzo V, Danesi C, Zanatta N

Fri-89

Candida species colonization and red autofluorescence of the dorsal tongueFederico A, Callea P, Patano A, Laudadio C, Benizio G, Della Vella F, Petruzzi M

Fri-90

Rare presentations of cranial nerve dysfunction associated with space-oc-cupying lesionsWillis A, Carey B, Gill D, Porter S

Fri-91

Morphometric Analysis of the ana-tomical variables of the maxillary sinus and the alveolar artery using Cone Beam Computed Tomography (CBCT)Guerrero Sánchez Y, López Jornet P, Parra Pérez F

Fri-92

Resistance to biocides in oral Staphy-lococcus aureusHijazi K, Mukhopadhya I, Oggioni M, Smith A, Gould I

Fri-93

Prevalence of human papillomavirus in saliva of women with HPV-related genital lesionsParcharidis E, Poulopoulos A, Andreadis D, Nasioutziki M, Kolokotronis A

Sat-01

Impact of the 2007 American Heart Association’s antibiotic prophylaxis guidelines on antibiotic prophylaxis prescribing and incidence of infective endocarditis in the USAThornhill M, Teresa G, Cutler E, Dayer M, Chu V, Lockhart P, O’gara P, Baddour L

Sat-02

In vivro and ex vivo evaluation of tab-lets containing piroxicam-cyclodex-trin complexes for buccal deliveryAndreadis D, Kontogiannidou E, Ferrari M, Bouropoulos N, Klepetsanis P, Sorenti M, Catenacci L, Poulopoulos A, Fatouros D

Sat-03

Electrospun fibres deliver lidocaine HCL to porcine buccal mucosa: an ex vivo permeation and MALDI-MS imag-ing studyClitherow K, Bay Stie M, Handler A, Janfelt C, Moerck Nielsen H, Hansen J, Hatton P, Spain S, Murdoch C, Jacobsen J

Sat-04

Systemic medication of patients with oral lichen planus in Turku university hospitalHeinonen M, Hieta N, Willberg J

Sat-05

A pigmented palate - hydroxychloro-quine-related oral hyperpigmentationMokhlesi L, Chaudhry S

Sat-06

Oral side effects of chemotherapy -- cross sectional studyGarcia - Chias B, Figuero E, Castelo - Fer-nandez B, Cebrian - Carretero J, Cerero - Lapiedra R

Sat-07

Role of periapical diseases in develop-ment of medication-related osteone-crosis of the jawRao N, Zheng L

Sat-08

Tumor-like gingival overgrowth induced by calcium channel blocking agentsKim J

Sat-09

Angioedema of lower lip and gingiva due to oral hormonal therapySkrinjar I, Loncar Brzak B, Carek A

Sat-10

Oral mucosal lesions as a side effect of antituberculosis drugsAk G, Akbiyik Az Z, Hacioglu E, Yurtseven A

Sat-11

Steroid-based inhalers are remark-ably associated with occurrence of oral hairy leukoplakia in HIV-negative patientsNama N, Vered M, Grinstein Koren O, Katz L, Zlotogorski Hurvitz A

Posters Saturday

2524

Sat-12

Oral cooling distribution using Co-oral™ and ice chipsMahdi A, Jontell M, Walladbegi J

Sat-13

The oral manifestations of psychiatric disordersHamadah O, Alhaffar M, Abbas G, Latiefeh Y

Sat-14

Risk factors influencing gingival enlargement in renal transplant pa-tients medicated with tacrolimusCasañas E, López-Pintor R, De Andres A, De Arriba L, De Pedro M, Ramirez L, Hernán-dez G

Sat-15

Purulent drainage as a prognostic factor to be considered when plan-ning the surgical approach to medica-tion-related osteonecrosis of the jawMarino R, Campolongo M, Val M, Pente-nero M

Sat-16

Oral and peri-implant conditions of patients at risk for medication-relat-ed osteonecrosis of the jaw (MRONJ)Vecchiatini R, Xaiz S, Frassoldati A, Cuneo A, Trombelli L

Sat-17

Alterations of mucosal vasculature at early stages of osteonecrosis of the jawsGkouveris I, Hadaya D, Soundia A, Nikitakis N, Bezouglaia O, Dry S, Pirih F, Aghaloo T, Tetradis S

Sat-18

Oral erythroplakia: a series of six casesSiponen M, Lajolo C

Sat-19

Co-morbidities in oral lichen planus a prospective hospital-based case-con-trol studyKarimi D, Gambino A, Cabras M, Broccoletti R, Arduino P

Sat-20

Presence of p16 protein in oral lichen planus (OLP) tissue samples and its connection with malignant transfor-mationHadzi-Mihailovic M, Zoric B, Stanimirovic D, Raybaud H

Sat-21

Malignant transformation of oral leukoplakia in a well-defined cohort of 162 patients with a long-term fol-low-upBrouns E, Karagozoglu H, Forouzanfar T, Bloemena E, De Visscher J

Sat-22

Epithelial dysplasia in oral mucosal disease - importance in control of oral candidiasis: 4-year follow up case reportKo D, Shim Y

Sat-23

Dioxide carbon laser treatment of 36 cases of oral leukoplakiaBarreira E, Salazar F, Pacheco J, Monteiro L

Sat-24

Analysis of haplotypes of gene poly-morphisms (TLR3 and TLR4) in OLPStanimirovic D, Hadzi-Mihailovic M, Zoric B, Zeljic K

Sat-25

Recurrence rate after surgical remov-al of oral leukoplakiaKorytowska M, Sundberg J, Blomgren J, Bratel J, Miranda Burgos P, Kjellström E, Öhman J, Kovács A, Sand L, Hirsch J, Holm-berg E, Giglio D, Kjeller G, Hasséus B

Sat-26

Leukoplakia and OSCCSepic Matanovic B, Molnar M, Pazin B, Radman M

Sat-27

Contact endoscopy and laser treat-ment of oral leukoplakia - a new protocol proposalGalrito M, Santos A, Monteiro L, Salvado F, Macor C

Sat-28

PD-1 expressing cells in leukoplakia and oral lichen planusDafar A, Siarov A, Robledo-Sierra J, Sundberg J, De Lara S, Giglio D, Öhman J, Hasséus B

Sat-29

Awareness among medical and dental undergraduates of benign and poten-tially malignant disorders and lesionsMakwana M, Keat R, Albuquerque R, Pove-da Gallego A, Higham J, Richards A

Sat-30

The recurrence of oral leukoplakia after surgical treatment with diode laser versus conventional surgeryKhalilaeva E, Kharitonova M

Sat-31

Oral epithelial dysplasia: ten-year ret-rospective from Istanbul universityBektas Kayhan K, Biltekin H, Bilgic B

Sat-32

Do nutraceuticals and herbal med-icines have a role in managing oral lichen planus? A systematic reviewAli S, Abdelkawy M, Wahbi W

Sat-33

Autophagy-related IRGM in patients with oral lichen planusZhou G, Tan Y, Zhang J, Ma R

Sat-34

Update on the development of a novel treatment for oral lichen planus (OLP) - the Rivelin® patchRuzicka T, Seegräber M, Bieber T, Homey B, Ni Riordain R, Siim Madsen L, Hansen J

Sat-35

The role of mucosal associated invari-ant T (MAIT) cells in oral lichen planus (OLP)Deangelis L, Cirillo N, Gonzalez A, Mccul-lough M

Sat-36

Some cases of proliferative multifo-cal leukoplakia could come from oral lichenoid disease with plaque lesions?Aguirre J, Aguirre J, Alberdi-Navarro J, Gross-Trujillo E, García-Chías B, Echebar-ria-Goikouria M, Cerero-Lapiedra R

2726

Sat-37

Expression of ER stress related mol-ecules - GRP78 and CHOP - in oral lichen planusShim Y

Sat-38

The equivocal diagnosis of oral lichenoid lesions appearing after rit-uximab administrationPessing Shabi A, Vered M, Zlotogorski Hurvitz A

Sat-39

Oral Lichen Planus: a single center experienceAlhelo A, Almazrooa S, Alfarabi S, Akeel S, Binmadi N, Alhindi N, Alsulaimani L, Mansour G,Mawardi H

Sat-40

Unidirectional delivery of clo-betasol-17-propionate using a novel mucoadhesive bilayer patch to treat oral lichen planus; a pre-clinical eval-uationColley H, Santocildes-Romero M, Hansen J, Siim Madsen L, Thornhill M, Hatton P, Murdoch C

Sat-41

Long term OLP transforming to OSCCMolnar M, Sepic Matanovic B, Pazin B

Sat-42

Temporomandibular disorders in pa-tients with cleft lip and palatePhoon Nguyen A, Nicholls W, Balasubrama-niam R

Sat-43

Psychological factors influencing decision making for trauma-related pain in the adolescent TMD patients: a case-control studyLee Y, Lee K, Auh Q

Sat-44

The impact of group intervention on patients with temporomandibular disorderGokhale A, Yap T, Heaphy N, Mccullough M

Sat-45

Analysis of differential gene expres-sion in temporal tendons of patients with masticatory muscle tendon-apo-neurosis hyperplasia by using next-generation sequencingYumoto M, Sato T, Mizuno Y, Endo M, Kawata Y, Yoda T

Sat-46

Eagle’s syndrome: a lingual paresthe-sia in a patient affected by osteogene-sis imperfectaBianchi S, Moreschi C, Cefis N, Romandini W, Lissoni A, Gastaldi G, Abati S

Sat-47

Association between pain, horizontal condylar angle, and degenerative changes in the temporomandibular joint: longitudinal study using CBCTPark M, Bae S, Kim C, Kim Y

Sat-48

Salivary concentrations of antioxi-dants and cortisol in patients with chronic temporomandibular disordersAlajbeg I, Vrbanović E, Lapić I, Rogić D, Alajbeg I

Sat-49

Juvenile idiopathic arthritis with severe unilateral temporomandibular joint involvementFerrazzo V, Guerino P, Assaf D, Marquezan M, Ferrazzo K

Sat-50

The potential relationship between nasal deformities and temporoman-dibular disorders (TMD)Alrashdan M, Alnuseirat A, Al-Omiri M

Sat-51

Distribution of facial pain and the risk of obstructive sleep apneaXu Y, Kodali S, Jadallah B, Arem S, Liu W, Syed A, Pinto A

Sat-52

Assessing diagnostic accuracy of ultrasonography and computed to-mography compared to the magnetic resonance imaging in the early detec-tion of rheumatoid-arthritis-related temporomandibular joint pathologyAlshaer S, Abdul-Hak M, Hajeer M, Hama-dah O

Sat-53

Leiomyoma of the oral cavity: the role of the differential diagnosisMoreschi C, Lissoni A, Freschi M, Gastaldi G, Vinci R, Abati S

Sat-54

Linear IgA in Saudi male adult with with prominent oral menifestations: A Case ReportFaden A, Alwakeel A, Alhamad K

Sat-55

The enigmatic nature of palatal ery-thematous lesions with histological psoriasiform patternZlotogorski Hurvitz A, Zadik Y, Gillman L, Platner O, Shani T, Goldman Y, Kaplan I, Vered M

Sat-56

Assessment of the quality of life in pa-tients undergoing treatment for oral submucous fibrosis in eastern Indian populationMisra S

Sat-57

Salivary calprotectin levels in patients with geographic tongueVegard G, Dafar A, Çevik-Aras H, Bratel J

Sat-58

Idiopathic oral ulceration with bone sequestration - a rare entityRaz E, Vered M, Kashkush H, Nama N, Brauner T, Littner D, Reiter S, Zlotogorski Hurvitz A

Sat-59

Traumatic neuroma of the lower lip and schwannoma of the tongue, two cases with diagnostic challengeAndreadis D, Stergiadou E, Anagnostou E, Poulopoulos A

Sat-60

Unusual pigmentary lesions of oral mucosa - case seriesNicolae C, Parlatescu I, Coculescu E, Tovaru S, Tovaru M

2928

Sat-61

Oral blue nevus - case reportCastilho G, Costa R, Pacheco J, Monteiro L

Sat-62

Migratory stomatitis. Case seriesPopa C, Filioreanu A, Tofan C, Coculescu B, Mihai L

Sat-63

The presentation of a mucosal kerato-cyst without syndromic involvementCapaldi F, Capaldi F, Currie R

Sat-64

Clinical and histological features of oral granulomatous inflammationWillberg J, Hollo T, Tamminen A

Sat-65

Eosinophilic ulcer: a case series of an intriguing oral mucosa lesionPoulopoulos A, Andreadis D, Nikitakis N, Mavroudis S, Anagnostou L

Sat-66

Oral leishmaniasis: a case reportBagán Debón L, Jiménez-Soriano Y, Ga-valdá-Esteve C, Margaix- Muñoz M, Bagán Sebastián J

Sat-67

Oral microbiome and oral mucositis in autologous hematopoietic stem cell transplantation recipientsLaheij A, Raber-Durlacher J, Kopppelmans R, Hazenberg M, Blijlevens N, Huysmans M, Potting C, van Leeuwen S, Brennan M, von Bültzingslöwen I, de Soet H, Buijs M, Brandt B, Rozema F, Zaura E

Sat-68

Fibrosis in labial salivary glands of patients with systemic autoimmune diseasesKatona K, Farkas N, Kneif M, Sütő G, Berki T, Balatonyi B, Tamás T

Sat-69

Electrostimulation of the lingual nerve by an intraoral device may lead to salivary gland regenerationWolff A, Koray M, Campisi G, Strietzel F, Lafaurie G, Beiski B, Ekström J

Sat-70

EBV and CMV em viral load in rheuma-toid arthritis and associated Sjögren’s syndromeGueiros L, Carvalho C, Lins-E-Silva M, Car-valho A, Duarte A, Leão J

Sat-71

A case of Sjögren’s syndrome com-plicated with cognitive impairment caused by autoimmune encephalitisFukushima Y, Isozaki Y, Endo M, Kitamura T, Kawata Y, Sato T

Sat-72

Dry mouth in hypertensive patientsRamirez Martinez Acitores L, Lopez-Pintor R, Corcuera M, Sanchez I, Casanas E, Marti-nez Acitores M, De Pedro M, Hernandez G

Sat-73

Purulent sialoadenitis in patients with primary Sjögren’s syndrome , a single center experienceŠembera M, Slezák R, Radochová V

Sat-74

Topical dry mouth products to treat xerostomia in patients with primary Sjögren’s syndrome: a double-blind clinical trialLópez-Pintor R, Ramírez L, Serrano J, Ca-sañas E, De Pedro M, Hernández G

Sat-75

Xeromeds consortium: The impact of medications on stimulated and unstimulated salivary flow rate in patients with Sjögren’s SyndromeFortuna G, Whitmire S, Aria M, Alajbeg I, Pedersen A, Di Fede O, Vissink A, Jager D, Andabak-Rogulj A, Jensen S, Noll J, Wolff A, Brennan M

Sat-76

SLE patients with secondary Sjögren´s syndrome are characterized by typical autoantibodies and a pro-inflamma-tory stateRuacho G, Ruacho G, Kvarnström M, Gus-tafsson J, Zickert A, Oke V, Rönnelid J, Elvin K, Gunnarsson I, Svenungsson E

Sat-77

Mucosal associated lymphoid tissue type lymphoma detected in the pa-rotid gland in a patient with undiag-nosed Sjogren’s SyndromeCohen H, Zalcman S, Nadler C, Aframian D

Sat-78

Patient with Sjögren’s syndrome suffering from severe hyposalivation treated successfully with sialoendos-copyZalcman S, Nadler C, Aframian D

Sat-79

Salivary gland dysfunction and xero-stomia in Sjögren’s syndrome: shear wave elastographyParra Pérez F, Guerrero Sánchez Y, Lopez Jornet P

Sat-80

Patient outcomes and gingival blood flow using laser doppler flowmetry following the use of episil® on free gingival graft donor sitesJames J, Weltman R, Kiat-Amnuay S, Eswa-ran S, Ayilavarapu S

Sat-81

Successful excision of tongue irrita-tional fibroma using 940 nm diode laserAl Otaibi L

Sat-82

Successful use of 940nm diode laser in oral soft tissue surgery: a case seriesAlmohaya M, Alotaibi L

Sat-83

Contamination of smartphones of dental students: a comparison with computer science studentsHalboub E, Alhazmi B, Al-Haider W, Al-Qu-hait H, Mujam O, Homeida H

Sat-84

Congenital absence of lingual frenum in a non-syndromic patient: a case reportFelemban R, Mawardi H

3130

Sat-85

Jaw cysts. A 37-year retrospective study according to the 2017 World Health Organization classificationTamiolakis P, Thermos G, Tosios K, Sklavou-nou-Andrikopoulou A

Sat-86

Characterization of oral medicine con-sultations in hospitalized patientsKeshet N, Weintraub C, Mazor S, Czerninski R

Sat-87

Odontogenic epithelial hamartoma of the gingiva: a case reportRubert Aparici A, Bagán Debón L, Vera Sempere F, Mosqueda A, Bagán Sebastián J

Sat-88

Rhinocerebral mucormycosis with extensive involvement. A case seriesKatoumas K, Nikitakis N, Fyrgiola M, Bouklas D, Kakiopoulos G, Gravvanis A, Anterriotis D

Sat-89

Immunohistochemical expression of EDA and EDAR in odontogenic kerato-cystsTamiolakis P, Tosios K, Piperi E, Sklavou-nou-Andrikopoulou A

Sat-90

Unusual case of osteonecrosis with-out a clear causeDemir M, Bektaş-Kayhan K, Soluk-TekkeşIn M, Topcuoglu N

Sat-91

Readability of online materials for oral ulcerationsNik Mohd Rosdy N, Mohd Ishak N, Wan Marizam W

Sat-92

Taste perception in patients with oral lichen planus with and without tongue lesionsSuter V, Negoias S, Friedrich H, Landis B, Caversaccio M, Bornstein M

Conference venue Lindholmen Conference Centre Address: Lindholmen Science Park, Lind-holmspiren 5, Gothenburg

Registration fees EAOM Member: 5100 SEK excl. vat Non EAOM Member: 6400 SEK excl. vat Postgraduate Student: 5100 SEK excl. vat Undergraduate Student: 1950 SEK excl. vat WWOM Member (non EAOM Member): 5800 SEK excl. vat

Badges Delegates and exhibitors are kindly requested to wear badges during all congress activities. Entry will not be permitted without a badge.

Wi-Fi Name: Lindholmen Guest No password needed.

Speakers instructionsMake sure that you turn up well before your session starts to meet your session chair and the other speakers. Bring a copy of your presentation on a USB flash drive to the room. Please upload and test your presentation in time before your session starts.

Local transportation in Gothenburg Lindholmen Conference Centre  is located in Lindholmen Science Park.

The bus stop is called: Lindholmen The boat stop is called: Lindholmspiren

Tickets and time tableFor travel information and travel planner download the app “Vasttrafik” travel planner or visit the website: www.vast-trafik.se Nordic delegates can also use

the travel planner and pay the trip via the the app “To Go”.

General information

You can buy a day card or 3 day card ticket in most convenience stores such as Pressbyrån, 7-eleven etc.

You can pay with credit card on the trams but not on the buses (then you have to buy a ticket in advance).

Please note that no cash are accepted on buses, boats or trams.

By busOne good way to get to Lindholmen is by bus. Line 16 departs every three minutes during high traffic in the morning and in the evening. During the day, it departs every ten minutes. It takes 6-8 minutes from the Central Station (Nordstan) to Lindholmen.

By ferryThe ferries “Älvsnabbare” offers free rides and departs every five to ten minutes from Stenpiren or Rosenlund (close to Järntorget) to Lindholmspiren. The trip will take about 5 minutes and the free shuttle is available betwen 7am and 7pm.

There is also a pay ferry called “Älvsnabben” boat number 285 that runs between Lilla Bommen – Stenpiren – Lindholmspiren – Slottsberget – Eriks-berg – Klippan. This boat runs longer hours and you can pay with credit card on the boat or with Västtrafik travel card.

3332

The stop “Lindholmspiren” is situated right in front of the Lindholmen Science Park area.

Visitor’s guide to Gothenburg and West Sweden Visit www.goteborg.com and www.vastsverige.com

The app “goteborg” is also very useful.

Messages During the conference messages may be directed to eaom2018@meetx.se or by calling the conference secretariat on +46 (0)31 708 84 90.

Disclaimer of liability Neither the local organizing committee nor EAOM will assume any responsibility for accidents, loss or damages as delays or modifications in the programme caused by unforeseen circumstances. Participants must arrange their own travel and health insurance.

Poster exhibition The poster exhibition is located in the rear of the main lecture hall and adja-cent areas. There will be two sessions. Posters in Session I will be displayed Friday between 7:45-17:15 and Session II on Saturday between 7:45-17:30. Poster presenters are kindly asked to hang and take down posters within the time ranges stated above. Neither the Local Organizing Committee nor the Professi-onal Congress Organizer Sweden Meetx can assist in sending posters by post to the authors after the congress.

Abstract collection Abstracts are available in the online detailed programme that can be found on the website www.eaom2018.se and in the web based app that has been sent to you in a text message. The abstracts are also found on a flash memory in the conference bag.

Awards overview The European Association of Oral Medicine recognizes the outstanding contribution of EAOM members to the biennial meeting by presenting awards for basic science, translational and clinical research. As well as awards for oral presentations, the most outstanding posters and young investigator/clinicians are recognized. The award winners will be presented at the Gala Dinner Satur-day night.

Conference DinnerDate: Saturday 29 September Time: 19:30-00:30 Place: Kajskjul 8, Packhuskajen 11 Website: www.kajskjul8.se Closest tram/bus/ferry stop: Stenpiren or Lilla Bommen

The EAOM 2018 Congress Dinner will take place at Kajskjul 8, a venue located in the harbour area in the city centre. Kajskjul 8 was built on the quays along the railroad tracks around 1870. Ori-ginally used as a warehouse, the shed was then filled with all kinds of products, such as spices imported from the Orient as well as lumber from the forests of Värmland ( the region north of Gothen-burg), which would then be transported down to southern Europe and other places. It is a building with a lot of inte-resting history, nowdays used for events and dinners.

Dinner includes entertainment, a three course dinner and beverages.

Lindholmen Science Center Photo Anders Wester

3534

4. Astro Sweden AB5. Colgate6. BrainCool AB (publ)7. Camurus8. Proxident AB9. Zendium10. Vigilant Biosciences, Inc.

11. Uriform AB / Lasal AS12. Mun-H-Center13. Trimb Healthcare14. Mun- & Halscancerförbundet15. Sunstar Sverige AB16. Dermtreat Aps17. SOM - Svensk förening för Orofacial Medicin

Exhibition & Floorplan

1. Gold Sponsor DenMat DentMan

2. Bronze Sponsor Dental Terapeutics

3. Silver Sponsor Nobel Biocare/Orascoptic

MHCF

BrainCool

Posters Posters

Posters

Posters

PostersConference Hall

3736

The ceramic implant renaissance is here. Add a splash of life to your portfolio with a new solution that taps into natural biology, beauty and beyond. A harmonic exhibition of strength and soft-tissue support that is 100 % metal free. That’s the unique NobelPearl. » nobelbiocare.com/pearl

NobelPearl™

GMT 57080 © Nobel Biocare Services AG, 2018. All rights reserved. Distributed by: Nobel Biocare. Nobel Biocare, the Nobel Biocare logotype and all other trademarks are, if nothing else is stated or is evident from the context in a certain case, trademarks of Nobel Biocare. Please refer to nobelbiocare.com/trademarks for more information. Product images are not necessarily to scale. Disclaimer: Some products may not be regulatory cleared/released for sale in all markets. Please contact the local Nobel Biocare sales office for current product assortment and availability. For prescription use only. Caution: Federal (United States) law restricts this device to sale by or on the order of a licensed dentist. See Instructions for Use for full prescribing information, including indications, contraindications, warnings and precautions.

A splash of life

SE_2018_NobelPearl ad_EAOM.indd 1 2018-08-29 15:03:16

WELCOME TO EAOM 2020

3938

Notes

4140

Notes

4342

Notes

14TH BIENNIAL CONGRESS OF EAOM INCONJUNCTION WITH THE WORLD WORKSHOPVII ON ORAL MEDICINELindholmen Science Park, Gothenburg - 27th to 29th September 2018